These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12741319)

  • 1. [Enhanced activity of rifampicin loaded with polybutyl cyanoacrylate nanoparticles in relation to intracellularly localized bacteria].
    Skidan IN; Gel'perina SE; Severin SE; Guliaev AE
    Antibiot Khimioter; 2003; 48(1):23-6. PubMed ID: 12741319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-lamellar lyotropic liquid crystalline nanoparticles enhance the antibacterial effects of rifampicin against Staphylococcus aureus.
    Tran N; Hocquet M; Eon B; Sangwan P; Ratcliffe J; Hinton TM; White J; Ozcelik B; Reynolds NP; Muir BW
    J Colloid Interface Sci; 2018 Jun; 519():107-118. PubMed ID: 29486430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactic-
    Maghrebi S; Joyce P; Jambhrunkar M; Thomas N; Prestidge CA
    ACS Appl Mater Interfaces; 2020 Feb; 12(7):8030-8039. PubMed ID: 32013379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
    Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
    Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibacterial activity of a new 3-azinomethyl-rifamycin.
    Strippoli V; Bruzzese T; Galli R; Simonetti N; Tronci N
    Farmaco Sci; 1988; 43(7-8):619-25. PubMed ID: 3147199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment.
    Vieira AC; Magalhães J; Rocha S; Cardoso MS; Santos SG; Borges M; Pinheiro M; Reis S
    Nanomedicine (Lond); 2017 Dec; 12(24):2721-2736. PubMed ID: 29119867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus.
    Ghaderkhani J; Yousefimashouf R; Arabestani M; Roshanaei G; Asl SS; Abbasalipourkabir R
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1181-1193. PubMed ID: 30942627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro controlled release of Rifampicin through liquid-crystalline folate nanoparticles.
    Parmar R; Misra R; Mohanty S
    Colloids Surf B Biointerfaces; 2015 May; 129():198-205. PubMed ID: 25863713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation.
    Zaru M; Sinico C; De Logu A; Caddeo C; Lai F; Manca ML; Fadda AM
    J Liposome Res; 2009; 19(1):68-76. PubMed ID: 19515009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of rifampicin against Staphylococcus aureus in vitro and in an experimental infection in normal and granulocytopenic mice.
    Hoogeterp JJ; Mattie H; Krul AM; van Furth R
    Scand J Infect Dis; 1988; 20(6):649-56. PubMed ID: 2975827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of experimental staphylococcal mastitis in the mouse with cloxacillin and rifampicin, alone and in combination.
    Craven N; Anderson JC
    Res Vet Sci; 1981 Nov; 31(3):295-300. PubMed ID: 6919178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Linezolid Serum Concentrations in Three Critically Ill Patients: Clinical Case Studies of a Potential Drug Interaction between Linezolid and Rifampicin.
    Blassmann U; Roehr AC; Frey OR; Koeberer A; Briegel J; Huge V; Vetter-Kerkhoff C
    Pharmacology; 2016; 98(1-2):51-5. PubMed ID: 27046487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo.
    Wang XF; Zhang SL; Zhu LY; Xie SY; Dong Z; Wang Y; Zhou WZ
    Vet J; 2012 Jan; 191(1):115-20. PubMed ID: 21900026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis.
    Chaubey P; Mishra B
    Carbohydr Polym; 2014 Jan; 101():1101-8. PubMed ID: 24299880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activities of rifabutine and rifampicin against Mycobacterium avium complex infections in mice and in peritoneal macrophages].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):173-9. PubMed ID: 2836650
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibacterial activity of rifampicin against the causative agents of suppurative, septic diseases].
    Samoĭlova LN; Fomina IP; Bodunkova LE
    Antibiotiki; 1977 Jan; 22(1):46-50. PubMed ID: 402885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model.
    Yu J; Wu J; Francis KP; Purchio TF; Kadurugamuwa JL
    J Antimicrob Chemother; 2005 Apr; 55(4):528-34. PubMed ID: 15743898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
    J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.